Association of antibiotic treatment with survival outcomes in treatment-naïve melanoma patients receiving immune checkpoint blockade
European Journal of Cancer · 2024-03 · 200 · 113536
DOI: 10.1016/j.ejca.2024.113536 ↗Kurz gefasst
Multizentrische Studie in der Zeitschrift European Journal of Cancer, 2024-03. Verfasst von Eleftheria Chorti und 20 weiteren Autor:innen. Beteiligte Einrichtung: Department of Dermatology, Essen University Hospital, West German Cancer Center, University of Duisburg-Essen and the German Cancer Consortium (DKTK)…. Hauptthemen laut MEDLINE: Anti-Bacterial Agents, Immune Checkpoint Inhibitors, Melanoma. Die Arbeit wurde bisher 17-mal zitiert (Crossref) und nennt 39 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Dermatology, Essen University Hospital, West German Cancer Center, University of Duisburg-Essen and the German Cancer Consortium (DKTK), partner site Essen/Düsseldorf, Germany.
- Institute of Medical Informatics, Biometry and Epidemiology (IMIBE), University Hospital Essen, Hufelandstr. 55, 45147 Essen, Germany.
- Skin Cancer Center, Department of Dermatology and National Center for Tumor Diseases (NCT), University Hospital Heidelberg, Im Neuenheimer Feld 460, 69120 Heidelberg, Germany.
- Department of Dermatology, Venereology and Allergology, University Hospital Würzburg, Würzburg, Germany.
- Department of Dermatology, Allergology and Phlebology, Bremerhaven Reinkenheide Hospital, Bremerhaven, Germany.
- Department of Dermatology, Skin Cancer Center Hannover, Hannover Medical School, Hannover and Johannes Wesling Medical Center Ruhr University Bochum, Minden, Germany.
Zitieren
APA
Chorti, E., Kowall, B., Hassel, J. C., Schilling, B., Sachse, M., Gutzmer, R., Loquai, C., Kähler, K. C., Hüsing, A., Gilde, C., Thielmann, C. M., Zaremba-Montenari, A., Placke, J. M., Gratsias, E., Martaki, A., Roesch, A., Ugurel, S., Schadendorf, D., Livingstone, E., …, & Zimmer, L. (2024). Association of antibiotic treatment with survival outcomes in treatment-naïve melanoma patients receiving immune checkpoint blockade. European Journal of Cancer, 200, 113536. https://doi.org/10.1016/j.ejca.2024.113536
Vancouver
Chorti E, Kowall B, Hassel JC, Schilling B, Sachse M, Gutzmer R, et al. Association of antibiotic treatment with survival outcomes in treatment-naïve melanoma patients receiving immune checkpoint blockade. European Journal of Cancer. 2024;200:113536. doi:10.1016/j.ejca.2024.113536
BibTeX
@article{Chorti2024,
author = {Chorti, Eleftheria and Kowall, Bernd and Hassel, Jessica C and Schilling, Bastian and Sachse, Michael and Gutzmer, Ralf and Loquai, Carmen and Kähler, Katharina C and Hüsing, Anika and Gilde, Catharina and Thielmann, Carl M and Zaremba-Montenari, Anne and Placke, Jan-Malte and Gratsias, Emmanouil and Martaki, Anna and Roesch, Alexander and Ugurel, Selma and Schadendorf, Dirk and Livingstone, Elisabeth and Stang, Andreas and Zimmer, Lisa},
title = {Association of antibiotic treatment with survival outcomes in treatment-naïve melanoma patients receiving immune checkpoint blockade},
journal = {European Journal of Cancer},
year = {2024},
volume = {200},
pages = {113536},
doi = {10.1016/j.ejca.2024.113536}
}
EUVIMED